# A Study to Evaluate the Safety and Tolerability of ABBV-0805 in Patients With Parkinson's Disease

> **NCT04127695** · PHASE1 · WITHDRAWN · sponsor: **AbbVie**

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** ABBV-0805
- **DRUG:** Placebo ABBV-0805

## Key facts

- **NCT ID:** NCT04127695
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-03-03
- **Primary completion:** 2020-06-16
- **Final completion:** 2020-06-16
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Strategic considerations
- **Last updated:** 2021-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04127695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04127695, "A Study to Evaluate the Safety and Tolerability of ABBV-0805 in Patients With Parkinson's Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04127695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*